Predicta Biosciences Raises $23.4M in Series A

Predicta Biosciences has successfully raised $23.4M in a Series A led by Engine Ventures.

Company Overview

Predicta Biosciences is a HealthTech company headquartered in Cambridge, MA, founded in 2020 with 40+ employees.

Precision medicine platform for predictive biomarker discovery

Fundraising Details

Amount Raised: $23.4M
Round Type: Series A
Date: 2025-08-18
Investors: Engine Ventures

About Predicta Biosciences

Precision medicine platform for predictive biomarker discovery The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Cambridge, MA
Founded: 2020
Team Size: 40+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Predicta Biosciences's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Predicta Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.

Looking Ahead

With this new capital, Predicta Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-08-18. For more information about Predicta Biosciences, visit their headquarters at Cambridge, MA.